Gsa Capital Partners LLP Infla Rx N.V. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.25 - $3.03 $104,924 - $141,297	-46,633 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$2.72 - $4.04 $126,841 - $188,397	46,633 New	46,633 $139,000
Q3 2020 Nov 06, 2020	SELL	$3.7 - $5.47 $126,358 - $186,805	-34,151 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$4.59 - $8.96 $156,753 - $305,992	34,151 New	34,151 $157,000

13.8M

12.9K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $76.5M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.